Immunology Faculty Member - Peter Schur, MD

Peter Schur, MD

Brigham and Women's Hospital
Dept. of Rheumatology/Immunology, PBB-B2
75 Francis Street
Boston, MA 2115
Tel: 617-732-5350
Fax: 617-732-5505
Email: pschur@partners.org



My research revolves around the following: Genetics of Systemic Lupus Erythematosus (SLE): In collaboration with Dr. Patricia Fraser and Karen Costenbader (Dept. of Medicine/Div. of Rheumatology BWH); we are continuing to explore the role of antibodies to acute phase reactants such as C-reactive protein (CRP) and tissue necrosis factor (TNF) as well as to citrullinated proteins (e.g. CCP) in patients with SLE, rheumatoid arthritis (RA) and related rheumatic and immune disorders; as well as the continued collaboration with Dr Shah Khoshbin (Dept Neurology, BWH) on Neuropsychiatric aspects of SLE; in collaboration with Dr E Massarotti (Rheumatology BWH) we are performing therapeutic trials of new medications for the treatment of SLE.






Last Update: 7/24/2014



Publications

Lee DM, Phillips R, Hagan EM, Chibnik LB, Costenbader KH, Schur PH. Quantifying anti-CCP titer: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis. Ann Rheum Dis 2009; 68:201-208

Liao, KP, Batra KL, Chibnik L, Schur PH, Costenbader KH. Anti-cyclic citrullinated peptide revised criteria for the classification of rheumatoid arthritis. Annals Rheum Dis 2008; 67:1557-1561.

Chibnik LB, Mandl LA, Costenbader KH, Schur PH, Karlson EW. Comparison of threshold cutpoints and ontinuous measures of anti-cyclic citrullinated peptide antibodies in predicting future rheumatoid arthritis. J Rheumatol 2009; 36: 706-11

Rosenau BJ, Schur PH. Autoantibodies to Tumor Necrosis Factor in patients with rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 2009; 36: 753-6

Rosenau BJ, Schur PH. Association of measles virus with rheumatoid arthritis. J Rheumatol 2009; 36:893-7.



© 2014 by the President and Fellows of Harvard College